Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Table 1 Demographic characteristics at the time of transplantation

From: CD14+CD16+ and CD14+CD163+ monocyte subpopulations in kidney allograft transplantation

  No induction   rATG   Basiliximab   P-value
Number 25   28   18   
Gender (male/female) 14/11   19/9   9/9   n.s.b
Recipient age (years) 57,9 [27.7; 73.3] 52,9 [21.5; 78.6] 52,9 [25.6; 67.1] n.s.d
Donor age (years) 52.0 [16.0; 68.0] 46.5 [22.0; 74.0] 63.5 [46.0; 75.0] <0.001d,e
aHLA MM 3 [1; 6]   [2; 5]   [1; 5] n.s.d
1st/2nd and 3rd T x R (n) 25/0   12/16   18/0   <0.0001b
aPRA (%) 4 [0; 36] 64 [0; 96] 7 [0; 44] <0.0001d,g
aCNI (TAC/CsA)(n) 21/4   28/0   18/0   n.s.b
aCIT (hours) 15.2 [11.0; 20.7] 15.9 [7.7; 22.8] 17.6 [12.4; 21.0] n.s.d
Dialysis time (years) 2.0 [0.2; 9.42] 2.2 [0.5; 6.37] 2.1 [0; 4.9] n.s.d
Cause of renal failure        n.s.
Primary GN 10   10   5   
Hereditary diseases 4   6   6   
Diabetic or ischaemic nephropathy 8   2   5   
aTIN 2   3   1   
aANCA vasculitis or lupus nephritis 0   4   0   
Other causes 1   3   1   
  1. aANCA, anti-neutrophil cytoplasmic antibodies; CIT, cold ischaemic time; CNI, calcineurin inhibitor; CsA, cyclosporine A; GN, glomerulonephritis; HLA MM, HLA mismatch; PRA, historical panel reactive antibodies, measured every 3 months before transplantation, the highest number was considered in each patient; TAC, tacrolimus; TIN, tubulointerstitial nephritis; T 3, renal transplantation.
  2. bChi square test P-value.
  3. dKruskal–Wallis test P value.
  4. eDunn’s multiple comparison test: significant difference between the basiliximab group and the rATG or controls.
  5. gDunn’s multiple comparison test: significantp difference between rATG and the no induction or basiliximab groups.